Search All News
A pilot feasibility study to assess a new therapy addresses a critical gap in treatment options for a high-risk patient population with unique emotional needs.
A new study from Columbia researchers links soccer heading to a decline in brain structure and function over a two-year period.
A new study shows that omitting aspirin from an anti-clotting regimen can improve outcomes for people living with a heart pump by reducing hospitalizations without increasing the risk of blood clots.
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
- May 28, 2021
The rapid shortening of the cell's telomeres between birth and age 3 may render telomeres particularly susceptible to environmental influences during this time, potentially influencing longevity.
- May 19, 2021
A new study describes multiple ways to achieve the same health benefits from exercise—as long as your exercise “cocktail” includes plenty of light physical activity.
- May 16, 2021
Brief pulses of ultrasound delivered to nerves near the kidney lowered blood pressure in people with drug-resistant hypertension, Columbia and NewYork-Presbyterian physicians have found.
- May 13, 2021
Scientists at Columbia took high-res images of a heat-sensing molecule in ground squirrels that could help researchers understand how we sense temperature and lead to the design of new pain relievers.
- May 10, 2021
A new study shows that silver nanoclusters—which could be applied to the treatment of cancer in the future—block an early step of DNA replication.
- April 27, 2021
Residents of some NYC public housing developments can get free vision screening and eye exams in their building as part of a new study led by Columbia University’s Department of Ophthalmology.
- April 22, 2021
A new imaging technique that can capture movies of individual receptors on the surface of living cells in unprecedented detail could pave the way to a trove of new drugs.
- March 30, 2021
With $16 million gift, Columbia will open a new center for Lyme and other tick-borne diseases this summer, offering patients specialized care and expanding research at a national level.
- March 16, 2021
A collaboration between Observational Health Data Sciences and Informatics (OHDSI) and Health Level Seven International (HL7) will improve access and sharing of health care data among researchers.
- March 9, 2021
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.